First domino, named next dominoes: management generalizes a fresh win into a repeatable template and points to the speci
The model's full reasoning — Q4 2017 call → NOWe need answer YES/NO based on transcript. Need determine if management explicitly generalizes a recent real success as repeatable template and identifies specific next places already in motion. Let's parse transcript. Company Intra-Cellular Therapies. Discusses lumateperone for schizophrenia, bipolar depression, agitation in dementia, etc. They have positive schizophrenia trials, NDA planned. They have open-label safety switching study completed, data presented. They have long-term open label safety study ongoing. They have Phase 3 bipolar depression studies, one monotherapy 401 topline H2 2018, 404 in 2019, adjunctive 402 expanding globally. They have Phase 3 agitation in Alzheimer's ongoing, interim analysis H2 2018. They plan late stage studies in depressive disorders in 2018. They have ITI-214 Phase 1/2 in Parkinson's ongoing, cohorts 1 and 2 completed, third ongoing, topline H2 2018. They have ITI-333 preclinical, plan clinic next year. Question asks: Does management take a RECENT, REAL SUCCESS the company has actually achieved — a won customer, completed project/deployment, successful product introduction, first site, market, program, or partnership that is now demonstrably working and producing real business — and explicitly GENERALIZE it, telling investors in substance: "what we just did here is not a one-off — it is a template we can repeat," AND does management identify the SPECIFIC NEXT PLACES where that same template is already being applied right now? Need look for such pattern. Management reports progress, but is there a specific success treated as template? For example, they completed a switching study in schizophrenia, showing safety. They might generalize to other indications? They say "These data provide important dosing guidance to healthcare providers on the ease of switching to lumateperone." But not necessarily template for next places. They have positive schizophrenia program, but they are filing NDA. They don't say "this success proves our approach and we are applying it to bipolar, dementia, depression" as a repeatable template? They do mention "We believe this unique pharmacology offers potential..." but not exactly a proven first instance as template. Let's examine.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| MCD | McDonald's Corporation | Q2 2024 | 2024-07-29 | D |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| GOLD | Barrick Gold Corporation | Q3 2023 | 2023-11-02 | C |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| UPWK | Upwork Inc. | Q2 2022 | 2022-07-27 | C+ |
| LOW | Lowe's Companies, Inc. | Q3 2021 | 2021-11-17 | B+ |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| ACHC | Acadia Healthcare Company, Inc. | Q4 2017 | 2018-02-22 | C+ |
T · Q3 2018 → YESThe question is: Does management take a RECENT, REAL SUCCESS and explicitly GENERALIZE it as a template they can repeat, AND identify SPECIFIC NEXT PLACES where that template is already being applied?...YES The transcript shows management treating the AdWorks success (22% revenue growth on a declining subscriber base) as a proven template for targeted advertising, then explicitly identifying the next applications: applying the same technology to Turner inventory and signing up additional distributors (Frontier and Altice) as concrete next repetitions already in motion. 5G and FirstNet do not qualify because their first instances are still prospective or ongoing without a completed, repeatable proof-of-concept.
LOW · Q3 2021 → YESThe question is about whether management takes a recent real success and generalizes it as a template they're applying to specific next places. YES The transcript shows management treating the market-based delivery model as a proven template after the first success in Florida and the second in Ohio Valley this quarter. They explicitly generalize it as a repeatable approach that is already driving measurable results (higher sales in appliances, improved margins, reduced inventory, higher on-time delivery) and plan 18+ months of rollout across the entire US.
FLR · Q2 2022 → YESThe question is about whether management takes a recent, real success and generalizes it as a template they can repeat, and identifies specific next places where it's being applied. YES The transcript shows management treating the LNG 1 project (awarded last quarter) as a proven template: David Constable states they have “proven that our mid-scale modular design and execution plans facilitates repeatable models that can be used to replicate and fast track similar LNG plants in the future.